Sana Biotechnology Q2 EPS $(0.45) Misses $(0.43) Estimate
Portfolio Pulse from Benzinga Newsdesk
Sana Biotechnology reported Q2 losses of $0.45 per share, missing the analyst consensus estimate of $0.43 by 4.65%. This is a 4.26% increase over losses from the same period last year.
August 04, 2023 | 2:41 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Sana Biotechnology's Q2 earnings missed analyst estimates, which could negatively impact the stock price in the short term.
Sana Biotechnology reported a larger than expected loss for Q2, missing analyst estimates. This could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100